Thanks for checking with IR Don. Although my prior experiences with companies that seemed overly zealous with withholding the raw numbers were not good, those companies also seemed to report contradictory information. So far with Lidak, I have not detected inconsistancies in what they have told me over a period of time. So I have chosen to trust the company and hope that has what they imply they have,,,a very promising drug.
Since they say that Bristol Meyers Sqibb and Yamanuchi have requested that the numbers be withheld, and since I have not heard of these 2 companies say it isn't true, and given Lidak's history of straight (if sparse) talk, I tend to believe them.
Lidak does have a history of completing and starting trials on time, if not a little early, so I think it is likely that they will file the NDA by the end of the year. How bout that Igen, Sepracor, and Cytyc...Later. |
